Tokyo has warned that a CBD roll-on sold in the capital contains a narcotic ingredient above the residual limit, making possession of the product illegal and prompting the metropolitan government to urge holders to surrender it.
The product is sold as RR Roll-On, in 88-milliliter bottles. Testing detected delta-9-THC (tetrahydrocannabinol) above the residual limit of 0.10ppm, ABEMA Times reported.
Tokyo said the item falls under the narcotics category of the Narcotics and Psychotropics Control Act. Selling, transferring, buying, possessing or using it is strictly regulated.
The metropolitan government said it has received no reports of health damage from the product. It is asking anyone who feels unwell after using it to see a doctor promptly.
What holders are asked to do
People who have the product should not use or sell it. They should come forward and follow instructions on voluntarily handing it over.
The metropolitan government set a deadline of Monday, November 16, 2026, for coming forward.
Product details
- Sales name: RR Roll-On
- Volume: 88 milliliters
- Lot number: M1500RO924
- Ingredients include water, isopropanol, menthol, arnica, peony root extract, licorice root extract, camphor, glycerin and cannabidiol
- Manufacturer and seller: YS Kikaku Co., Ltd., 2-3-7 Sengoku, Koto Ward, Tokyo
- Release company: CBDA Co., Ltd., Fukazawa Building 2F, 1-10-2 Asahimachi, Kashiwa, Chiba Prefecture
Tokyo inspects CBD and other cannabis-derived products sold in the capital to ensure they are distributed safely and properly. The check that flagged RR Roll-On was part of that program.